Release of PMN elastase, TGF-β1 and neopterin during blood storage; unfiltered versus filtered blood

Transfusion and Apheresis Science

Volumn 35, Issue 2, 2006, Pages 97-102

  Tylman, Maria ^a   Bengtson, Jan Peter ^a   Hyllner, Monica ^a   Bengtsson, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Blood storage; Leukocyte filtration; Neopterin; PMN elastase; TGF 1

Indexed keywords

CELL ENZYME; ELASTASE; NEOPTERIN; TRANSFORMING GROWTH FACTOR BETA1;

APHERESIS; ARTICLE; BLOOD DONOR; BLOOD FILTER; BLOOD FILTRATION; BLOOD SAMPLING; BLOOD STORAGE; CYTOKINE RELEASE; ENZYME ANALYSIS; ENZYME RELEASE; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; NORMAL HUMAN; PLASMA; POLYMORPHONUCLEAR CELL;

ADULT; BLOOD COMPONENT REMOVAL; BLOOD PRESERVATION; ERYTHROCYTES; FEMALE; HUMANS; LEUKOCYTES; MALE; NEOPTERIN; PANCREATIC ELASTASE; PLASMA; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33751202972     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.06.002     Document Type: Article

References (27)

1. McAlister F.A., Clark H.D., Wells P.S., and Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Brit J Surg 85 (1998) 171-178
2. Vamvakas E.C., and Blajchman M.A. Universal WBC reduction: the case for and against. Transfusion 41 (2001) 691-712
3. Fergusson D., Herbert P.C., Lee S.K., Walker C.R., Barrington K.J., Josef L., et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 289 (2003) 1941-1949
4. Hyllner M., Arnestad J.P., Bengtson J.P., Rydberg L., and Bengtsson A. Complement activation during storage of whole blood, red cells, plasma, and buffy coat. Transfusion 37 (1997) 264-268
5. Kristiansson M., Soop M., Saraste L., and Sundqvist K.G. Prestorage versus bedside white blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors. J Trauma 40 (1996) 379-383
6. Dzik S., Mincheff M., and Puppo F. Apoptosis, transforming growth factor-β, and the immunosuppressive effect of transfusion. Transfusion 42 (2002) 1221-1223
7. Mincheff M. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang 74 Suppl. 2 (1998) 189-200
8. Walport M.J., Davies K.A., and Botto M. C1q and systemic lupus erythematosus. Immunobiology 199 (1998) 265-285
9. Kalechman Y., Gafter U., Sobelman D., and Sredni B. The effect of a single whole blood transfusion on cytokine secretion. J Clin Immunol 10 (1990) 99-105
10. Wadhwa M., Krailadsiri P., Dilger P., Gaines D., Seghatchian M.J., and Thorpe R. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates. Vox Sang 83 (2002) 125-136
11. Uhlmann E.J., Isgriggs E., Wallermfechtel M., and Goodnough L.T. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 41 (2001) 997-1000
12. Heddle N.M., Blajchman M.A., Meyer R.M., Lipton J.H., Walker I.R., Sher G.D., et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 42 (2002) 556-566
13. Kristiansson M., Soop M., Saraste L., and Sundqvist K.G. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions?. Acta Anaesthesiol Scand 40 (1996) 496-501
14. Hyllner M., Tylman M., Bengtson J.P., and Bengtsson A. Complement activation in prestorage leucocyte-filtered plasma. Transfus Med 14 (2004) 45-52
15. Ertel W., Jarrar D., Jochum M., Thiele V., Kenny J., Faist E., et al. Enhanced release of elastase is not concomitant with increased secretion of granulocyte-activating cytokines in whole blood from patients with sepsis. Arch Surg 129 (1994) 90-97
16. Fuchs D., Weiss G., and Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 101 (1993) 1-6
17. Ruokonen E., Ilkka L., Niskanen M., and Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 46 (2002) 398-404
18. Plata-Nazar K., Kozielska E., and Luczak G. Clinical value of neopterin Part I. Med Wieku Rozwoj VIII 2Pt2 (2004) 433-437
19. Wahl S., McCartney-Francis N., Alles J., Dougherty E., and Dougherty S. Macrophage production of TGF-β and regulation by TGF-β. Ann NY Acad Sci 593 (1990) 188-196
20. Wahl S.M. TGF-β in the evolution and resolution of inflammatory and immune processes. Microbes Infect 1 (1999) 1247-1249
21. Kunz D., Luley C., Heim M.U., and Bock M. Transforming growth factor-β is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion 38 (1998) 156-159
22. Mynster T., Dybkjoer E., Kronborg G., and Nielsen H.J. Immunomodulating effect of blood transfusion: is storage time important?. Vox Sang 74 (1998) 176-181
23. Ahuja S.S., Paliogianni F., Yamada H., Balow J.E., and Boumpas D. Effect of transforming growth factor-β on early and late activation events in human T cells. J Immunol 150 (1993) 3109-3118
24. Frabetti F., Musiani D., Marini M., Fanelli C., Coppola S., Ghibelli L., et al. White cell apoptosis in packed red cells. Transfusion 38 (1998) 1082-1089
25. Nguyen L.T., Ramanathan M., Weinstock-Guttman B., Baier M., Brownscheidle C., and Jacobs L.D. Sex differences in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J Neurol Sci 209 1-2 (2003) 93-99
26. Grainger D.J. Transforming growth factor-β and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24 (2004) 399-404
27. Ivanovic V., Todorovic-Rakovic N., Demajo M., Neskovic-Konstantinovic Z., Subota V., Ivanisevic-Milovanovic O., et al. Elevated plasma levels of transforming growth factor-β 1 (TGF-β 1) in patients with advanced breast cancer: association with disease progression. Eur J Cancer 39 (2003) 454-461